TREA

86364737 - GEOSOC

Follow

Information

  • Trademark
  • 86364737
  • Serial Number
    86364737
  • Filing Date
    August 12, 2014
    10 years ago
  • Transaction Date
    April 15, 2021
    3 years ago
  • Status Date
    March 14, 2017
    7 years ago
  • Location Date
    March 14, 2017
    7 years ago
  • Status Code
    602
  • Current Location
    TMO LAW OFFICE 129 - EXAMINING ATTORNEY ASSIGNED
    Employee Name
    HENRY, NAKIA D
  • Attorney Docket Number
    KILB-0002
    Attorney Name
    Molly Buck Richard
    Law Office Assigned Location Code
    O20
  • Owners
Information
Mark Drawing Code
4000
Mark Identification
GEOSOC
Case File Statements
  • GS0051: Pharmaceuticals having a self-orienting effect, namely, orally delivered pharmaceuticals with modified time release into the gastrointestinal system; gastro retentive pharmaceuticals; self orienting pharmaceuticals in the form of capsules, namely, capsules consisting of segments of varied functions and absorption rates, resulting in controlled release into the gastrointestinal tract; Gastrointestinal drug delivery preparations for medical, surgical and biological purposes; chronotherapy-focused tablets, analgesics; bacterial preparations for medical and veterinary purposes; chemical preparations and reagents for pharmaceutical, medical and veterinary purposes; diagnostic preparations for medical and veterinary purposes; Medicines for treatment or prevention of cancer, infectious disease, fungal diseases, diseases caused by parasites, namely, hookworms, pinworms, roundworms, tapeworms, flukes, giardia, entameoba, cryptosporidium, toxoplasmosis, sleeping sickness, trichuriasis, isosporiasis, malaria, parasitic skin disease and leishmaniasis, eye diseases, diseases of the central and peripheral nervous systems, namely, ataxia, dementia, epilepsy, Alzheimer's, cerebral palsy, stroke, motor neuron disease, Parkinson's disease, spinal injury, avulsion injury and peripheral neuropathies, cardiovascular disease, diseases affecting the immune system, namely, cancer, Crohn's disease, AIDS, HIV, lupus, celiac disease, diabetes, Grave's disease, Guillain-Barré syndrome, Addison's disease, Hashimoto's disease, myasthenia gravis, narcolepsy, pernicious anaemia, rheumatoid arthritis, psoriasis, ulcerative colitis, immunodeficiency and inflammatory diseases, inherited diseases, namely, genetic disorders, hemophilia, cystic fibrosis and Huntingdon's, single gene disorders, bone and blood diseases and reproductive system disorders; medicinal preparations for treatment or prevention of cancer, infectious disease, fungal diseases, diseases caused by parasites, namely, hookworms, pinworms, roundworms, tapeworms, flukes, giardia, entameoba, cryptosporidium, toxoplasmosis, sleeping sickness, trichuriasis, isosporiasis, malaria, parasitic skin disease and leishmaniasis, eye diseases, diseases of the central and peripheral nervous systems, namely, ataxia, dementia, epilepsy, Alzheimer's, cerebral palsy, stroke, motor neuron disease, Parkinson's disease, spinal injury, avulsion injury and peripheral neuropathies, cardiovascular disease, diseases affecting the immune system, namely, cancer, Crohn's disease, AIDS, HIV, lupus, celiac disease, diabetes, Grave's disease, Guillain-Barré syndrome, Addison's disease, Hashimoto's disease, myasthenia gravis, narcolepsy, pernicious anaemia, rheumatoid arthritis, psoriasis, ulcerative colitis, immunodeficiency and inflammatory diseases, inherited diseases, namely, genetic disorders, hemophilia, cystic fibrosis and Huntingdon's, single gene disorders, bone and blood diseases and reproductive system disorders; capsules for the release of colonic drug delivery; pharmaceuticals for the treatment or prevention of cancer, infectious disease, fungal diseases, diseases caused by parasites, namely, hookworms, pinworms, roundworms, tapeworms, flukes, giardia, entameoba, cryptosporidium, toxoplasmosis, sleeping sickness, trichuriasis, isosporiasis, malaria, parasitic skin disease and leishmaniasis, eye diseases, diseases of the central and peripheral nervous systems, namely, ataxia, dementia, epilepsy, Alzheimer's, cerebral palsy, stroke, motor neuron disease, Parkinson's disease, spinal injury, avulsion injury and peripheral neuropathies, cardiovascular disease, diseases affecting the immune system, namely, cancer, Crohn's disease, AIDS, HIV, lupus, celiac disease, diabetes, Grave's disease, Guillain-Barré syndrome, Addison's disease, Hashimoto's disease, myasthenia gravis, narcolepsy, pernicious anaemia, rheumatoid arthritis, psoriasis, ulcerative colitis, immunodeficiency and inflammatory diseases, inherited diseases, namely, genetic disorders, hemophilia, cystic fibrosis and Huntingdon's, single gene disorders, bone and blood diseases and reproductive system disorders, medical and veterinary preparations for body slimming purposes; capsules, suppositories, tablets and pills for pharmaceutical, medical and veterinary purposes for the treatment or prevention of cancer, infectious disease, fungal diseases, diseases caused by parasites, namely, hookworms, pinworms, roundworms, tapeworms, flukes, giardia, entameoba, cryptosporidium, toxoplasmosis, sleeping sickness, trichuriasis, isosporiasis, malaria, parasitic skin disease and leishmaniasis, eye diseases, diseases of the central and peripheral nervous systems, namely, ataxia, dementia, epilepsy, Alzheimer's, cerebral palsy, stroke, motor neuron disease, Parkinson's disease, spinal injury, avulsion injury and peripheral neuropathies, cardiovascular disease, diseases affecting the immune system, namely, cancer, Crohn's disease, AIDS, HIV, lupus, celiac disease, diabetes, Grave's disease, Guillain-Barré syndrome, Addison's disease, Hashimoto's disease, myasthenia gravis, narcolepsy, pernicious anaemia, rheumatoid arthritis, psoriasis, ulcerative colitis, immunodeficiency and inflammatory diseases, inherited diseases, namely, genetic disorders, hemophilia, cystic fibrosis and Huntingdon's, single gene disorders, bone and blood diseases and reproductive system disorders; pre-filled vials containing medical diagnostic reagents
  • GS0101: Surgical apparatus and instruments for medical, dental or veterinary use; inhalers for medical purposes; injection apparatus, instruments and devices, namely, medical apparatus in the nature of an infusion injection device for administering drugs; apparatus, instruments and devices, namely, automated drug delivery systems for storing and dispensing medical, surgical and veterinary preparations, capsules, powders, tablets and pills; instruments and apparatus for the administration of self-orientation therapy and prophylaxis preparations and substances, namely, gastrointestinal drug delivery systems, syringes and fluid injectors for medical purposes; Pharmaceutical and veterinary preparations, namely, orally delivered gastroretentive drug delivery systems with modified time release into the gastrointestinal system
  • GS0421: Scientific and technological services, namely, consulting, research and design exclusively in the pharmaceuticals and medical fields; industrial analysis and research services exclusively in the pharmaceuticals and medical fields; design services exclusively in the pharmaceuticals and medical fields; drug development and custom design of pharmaceuticals and medical goods
  • GS0441: Medical services; veterinary services; hygienic care for human beings or animals; medical analysis for the diagnosis and treatment of persons treatment or prevention of cancer, infectious disease, fungal diseases, diseases caused by parasites, namely, hookworms, pinworms, roundworms, tapeworms, flukes, giardia, entameoba, cryptosporidium, toxoplasmosis, sleeping sickness, trichuriasis, isosporiasis, malaria, parasitic skin disease and leishmaniasis, eye diseases, diseases of the central and peripheral nervous systems, namely, ataxia, dementia, epilepsy, Alzheimer's, cerebral palsy, stroke, motor neuron disease, Parkinson's disease, spinal injury, avulsion injury and peripheral neuropathies, cardiovascular disease, diseases affecting the immune system, namely, cancer, Crohn's disease, AIDS, HIV, lupus, celiac disease, diabetes, Grave's disease, Guillain-Barré syndrome, Addison's disease, Hashimoto's disease, myasthenia gravis, narcolepsy, pernicious anaemia, rheumatoid arthritis, psoriasis, ulcerative colitis, immunodeficiency and inflammatory diseases, inherited diseases, namely, genetic disorders, hemophilia, cystic fibrosis and Huntingdon's, single gene disorders, bone and blood diseases and reproductive system disorders; pharmacy advice; provision of information relating to medical, surgical and veterinary matters online from a computer database or over the Internet
  • TR0010: The word(s) "GEOSOC" has no meaning in a foreign language.
Case File Event Statements
  • 3/14/2017 - 7 years ago
    26 - ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND Type: MAB2
  • 3/14/2017 - 7 years ago
    25 - ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE Type: ABN2
  • 8/15/2016 - 8 years ago
    24 - NOTIFICATION OF PRIORITY ACTION E-MAILED Type: GPRN
  • 8/15/2016 - 8 years ago
    23 - PRIORITY ACTION E-MAILED Type: GPRA
  • 8/15/2016 - 8 years ago
    22 - PRIORITY ACTION WRITTEN Type: CPRA
  • 7/20/2016 - 8 years ago
    21 - LIE CHECKED SUSP - TO ATTY FOR ACTION Type: RCCK
  • 7/14/2016 - 8 years ago
    20 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 7/14/2016 - 8 years ago
    19 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 7/14/2016 - 8 years ago
    18 - TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED Type: ERSI
  • 1/20/2016 - 9 years ago
    17 - NOTIFICATION OF LETTER OF SUSPENSION E-MAILED Type: GNS3
  • 1/20/2016 - 9 years ago
    16 - LETTER OF SUSPENSION E-MAILED Type: GNSL
  • 1/20/2016 - 9 years ago
    15 - SUSPENSION LETTER WRITTEN Type: CNSL
  • 12/29/2015 - 9 years ago
    14 - LIE CHECKED SUSP - TO ATTY FOR ACTION Type: RCCK
  • 6/25/2015 - 9 years ago
    13 - NOTIFICATION OF LETTER OF SUSPENSION E-MAILED Type: GNS3
  • 6/25/2015 - 9 years ago
    12 - LETTER OF SUSPENSION E-MAILED Type: GNSL
  • 6/25/2015 - 9 years ago
    11 - SUSPENSION LETTER WRITTEN Type: CNSL
  • 6/8/2015 - 9 years ago
    10 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 6/8/2015 - 9 years ago
    9 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 6/1/2015 - 9 years ago
    8 - ASSIGNED TO LIE Type: ALIE
  • 5/26/2015 - 9 years ago
    7 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 11/28/2014 - 10 years ago
    6 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN
  • 11/28/2014 - 10 years ago
    5 - NON-FINAL ACTION E-MAILED Type: GNRT
  • 11/28/2014 - 10 years ago
    4 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 11/25/2014 - 10 years ago
    3 - ASSIGNED TO EXAMINER Type: DOCK
  • 8/21/2014 - 10 years ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM Type: NWOS
  • 8/15/2014 - 10 years ago
    1 - NEW APPLICATION ENTERED IN TRAM Type: NWAP